KARDIOLOGIYA
Scope & Guideline
Elevating Insights in Cardiovascular Medicine
Introduction
Aims and Scopes
- Cardiovascular Disease Mechanisms and Pathophysiology:
Research exploring the underlying mechanisms of various cardiovascular conditions, including myocardial infarction, heart failure, and arrhythmias, is a core focus. This includes studies on biomarkers, genetic predispositions, and the effects of comorbidities such as diabetes and hypertension. - Innovative Diagnostic and Therapeutic Techniques:
KARDIOLOGIYA publishes studies on modern diagnostic methods, such as echocardiography, CT angiography, and cardiac MRI, along with evaluations of novel therapeutic approaches including pharmacological treatments and interventional procedures. - Management of Chronic Heart Failure:
Significant attention is given to the management strategies for chronic heart failure, including the latest insights into pharmacotherapy, rehabilitation, and the use of devices like implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy. - Cardio-Oncology:
The intersection of cardiology and oncology is increasingly represented, with research addressing cardiotoxicity from cancer therapies and the management of cardiovascular risks in cancer patients. - Public Health and Cardiovascular Epidemiology:
The journal also emphasizes epidemiological studies that assess risk factors, prevalence rates, and population health outcomes related to cardiovascular disease, particularly in the context of the Russian Federation.
Trending and Emerging
- Telemedicine and Remote Monitoring:
The increasing reliance on telemedicine for cardiovascular care, particularly post-COVID-19, highlights the importance of remote monitoring and digital health technologies in managing chronic cardiovascular diseases. - Heart Failure with Preserved Ejection Fraction (HFpEF):
Research focusing on HFpEF has surged, addressing its complex pathophysiology, diagnosis, and management strategies, reflecting growing recognition of this condition's prevalence and impact. - Cardio-Oncology Research:
The intersection of cardiology and oncology is increasingly represented, with a focus on understanding and mitigating the cardiovascular effects of cancer treatments, emphasizing the need for integrated care models. - The Role of Inflammation in Cardiovascular Disease:
Emerging studies are increasingly focusing on inflammatory processes as key contributors to cardiovascular pathology, integrating findings from immunology into cardiovascular research. - Personalized Medicine in Cardiovascular Care:
There's a growing trend towards personalized approaches in treating cardiovascular diseases, including the use of genetic and biomarker data to tailor therapies to individual patients.
Declining or Waning
- Traditional Risk Factor Studies:
While risk factors such as hypertension and hyperlipidemia remain relevant, there has been a noticeable decrease in studies focusing solely on these traditional risk factors without integrating newer biomarkers or genetic information. - Basic Science Research on Cardiovascular Pathways:
Research that delves into the fundamental biological mechanisms of cardiovascular diseases, such as cellular signaling pathways without clinical application, appears to be waning in favor of studies with direct clinical implications. - Invasive Surgical Techniques:
There is a shift away from traditional surgical methodologies towards less invasive procedures and medical management, leading to fewer publications on invasive surgical techniques and their outcomes.
Similar Journals
International Heart Journal
Advancing Cardiovascular Knowledge GloballyInternational Heart Journal, published by INT HEART JOURNAL ASSOC, serves as a pivotal platform for research and discourse in the fields of cardiology and cardiovascular medicine. With its ISSN 1349-2365 and E-ISSN 1349-3299, this esteemed journal is based in Japan and is located at the University of Tokyo, Graduate School of Medicine, Department of Cardiovascular Medicine. Since its inception in 2005, International Heart Journal has blossomed into a respected publication with an impact factor that signifies its growing relevance, ranking in the Q3 category of both cardiology and miscellaneous medicine as of 2023. This journal not only disseminates vital research findings but also fosters collaboration among researchers and healthcare professionals. Notable for its Open Access options, it ensures the availability of its content to a broader audience, thereby enhancing knowledge transfer and innovation in cardiovascular care. With an ongoing commitment to improve clinical practice and patient outcomes, the journal continues to be an essential resource for those dedicated to advancing the understanding of heart health and disease.
International Journal of Cardiology
Elevating Standards in Cardiology Research and PracticeThe International Journal of Cardiology is a premier publication in the field of Cardiology and Cardiovascular Medicine, published by Elsevier Ireland Ltd. With an impressive impact factor and ranked in the top quartile (Q1) of its category, this journal serves as a vital resource for researchers, clinicians, and scholars committed to advancing cardiovascular health. Founded in 1981, the journal has been pivotal in disseminating significant findings, with a wide-ranging scope that includes original research, reviews, and clinical studies aimed at improving patient outcomes and understanding heart diseases. Its robust ranking of #73 out of 387 in Scopus ensures that it remains a leading platform for impactful cardiovascular research. While currently not an open-access publication, the journal's commitment to quality and relevance makes it an essential reference point within an ever-evolving medical landscape. For those engaged in cardiovascular research, the International Journal of Cardiology is not just a journal; it's an indispensable source of knowledge shaping the future of heart health.
CARDIOVASCULAR RESEARCH
Innovating research for a healthier heart.CARDIOVASCULAR RESEARCH, published by Oxford University Press, is a premier academic journal dedicated to the evolving field of cardiology and cardiovascular medicine. With a remarkable impact factor reflecting its significant contribution to the scientific community, this journal maintains a Q1 ranking in both Cardiology and Physiology categories, demonstrating its commitment to publishing high-quality research that influences clinical practices and healthcare outcomes. Established in 1967, the journal has consistently provided a platform for innovative studies and reviews, aiming to advance our understanding of cardiovascular physiology and pathology. Researchers, professionals, and students will find published articles crucial for their work, as the journal covers a broad spectrum of topics including molecular biology, genetics, and clinical studies. While currently not offering open access options, CARDIOVASCULAR RESEARCH remains accessible through institutional and individual subscriptions, ensuring that the latest findings are available to those in the cardiovascular science community.
PROGRESS IN PEDIATRIC CARDIOLOGY
Shaping the Future of Pediatric CardiologyPROGRESS IN PEDIATRIC CARDIOLOGY is a notable journal dedicated to advancing research and knowledge in the fields of pediatric cardiology and cardiovascular health in children. Published by Elsevier Ireland Ltd, this journal serves as a vital resource for clinicians, researchers, and healthcare professionals who engage with the complexities of heart diseases affecting pediatric populations. With ISSN 1058-9813 for print and 1558-1519 for online issues, it operates from Ireland and reflects a commitment to disseminating high-quality, peer-reviewed research since its inception in 1992. The journal is ranked in the Q3 category in both cardiology and pediatrics, indicating its relevance in the academic community, despite recent performance metrics showing room for growth within the competitive landscape. Researchers and practitioners can expect to find cutting-edge findings and clinical studies that aim to improve outcomes in pediatric cardiology. While it does not offer Open Access, the breadth of research covers various critical aspects, contributing significantly to the field's ongoing development.
ACTA CARDIOLOGICA
Charting the future of heart health and medicine.ACTA CARDIOLOGICA is a distinguished journal published by TAYLOR & FRANCIS LTD, focusing on the dynamic fields of Cardiology and Cardiovascular Medicine. Established in 1946, the journal has maintained a significant presence in the academic community, providing a platform for cutting-edge research and clinical studies that aim to address challenges in cardiovascular health. With its Q3 rating in both Cardiology and General Medicine categories, it showcases a robust compilation of articles that reflect the evolving landscape of cardiac care. Although ACTA CARDIOLOGICA is not an Open Access journal, it continues to serve a vital role for researchers, professionals, and students dedicated to advancing knowledge in cardiovascular health. This journal, with an ISSN of 0001-5385 and E-ISSN of 1784-973X, is a critical resource for those looking to stay updated on the latest developments and practices in the specialization, contributing significantly to the field until 2024 and beyond.
BASIC RESEARCH IN CARDIOLOGY
Advancing cardiac science through groundbreaking research.BASIC RESEARCH IN CARDIOLOGY, published by SPRINGER HEIDELBERG, is an esteemed peer-reviewed journal dedicated to advancing the field of cardiology and cardiovascular medicine since 1973. With a strong emphasis on the latest breakthroughs in basic and translational research, this journal offers a platform for high-quality, impactful studies that contribute to our understanding of cardiac function and related physiological processes. Currently ranked in the Q1 category in Cardiology and Cardiovascular Medicine, as well as Physiology and Medical Physiology, BASIC RESEARCH IN CARDIOLOGY is recognized as a leading journal within these disciplines, boasting impressive Scopus ranks that place it in the top tiers of global research output. While it does not offer open access, its contributions are pivotal for researchers, clinicians, and students seeking to stay abreast of cutting-edge discoveries and methodologies in cardiovascular science. With its commitment to scholarly excellence, this journal plays a critical role in shaping the future of cardiac research and clinical practice.
American Journal of Cardiovascular Drugs
Unveiling Breakthroughs in Cardiovascular MedicineAmerican Journal of Cardiovascular Drugs, published by ADIS INT LTD, is a premier peer-reviewed journal dedicated to the field of cardiology and cardiovascular medicine. With an ISSN of 1175-3277 and an E-ISSN of 1179-187X, this esteemed journal has established itself as a crucial platform for disseminating high-quality research since its inception in 2001. It holds a significant position in its domain, ranking in the second quartile (Q2) across several categories including Cardiology, Medicine (miscellaneous), and Pharmacology (medical) for the year 2023. With its Scopus ranks placing it in the 81st percentile for Cardiology and 77th percentile for Pharmacology, the journal is highly regarded among professionals, researchers, and students alike. While it is not an open-access journal, its comprehensive articles and systematic reviews provide an in-depth exploration of cardiovascular drug therapy, therapeutic advancements, and clinical practices, making it an invaluable resource for anyone invested in the future of cardiovascular health.
Anatolian Journal of Cardiology
Advancing Cardiac Research Through Open Access Excellence.The Anatolian Journal of Cardiology, published by KARE PUBL, stands as a vital resource in the field of Cardiology and Cardiovascular Medicine. With an ISSN of 2149-2263 and E-ISSN 2149-2271, this Open Access journal has been fostering the dissemination of critical research since 2001, ensuring that high-quality content is freely available to a global audience. Based in Turkey, the journal aims to bridge gaps in cardiological knowledge through rigorous peer-reviewed articles that span a wide range of topics, from innovative clinical practices to groundbreaking research findings. While its current ranking places it in the Q3 category of cardiology journals, the Anatolian Journal of Cardiology continues to strive towards enhancing its impact, currently holding a Scopus rank of 236 out of 387. Researchers, practitioners, and students alike will find this journal an essential platform for keeping abreast of the latest developments in cardiovascular health.
Kardiologia Polska
Bridging Knowledge and Practice in CardiologyKardiologia Polska, the esteemed journal of the Polish Cardiac Society, has established itself as a vital resource in the field of cardiology and cardiovascular medicine since its inception in 1954. With an ISSN of 0022-9032 and an E-ISSN of 1897-4279, this journal serves as a platform for groundbreaking research and scholarly articles that contribute to the advancement of heart health. Although currently not an open access journal, it remains an essential reference for practitioners and researchers seeking to stay abreast of the latest developments in cardiovascular science. The journal reflects its scholarly depth through a Category Quartile of Q3 and a commendable Scopus ranking at the 48th percentile in its field. Published primarily in Poland, it caters to a global audience eager to explore comprehensive studies spanning clinical cardiology, innovative therapeutic approaches, and emerging cardiovascular trends. Join a thriving academic community by engaging with the invaluable insights and research contributions found within the pages of Kardiologia Polska.
Journal fur Kardiologie
Unveiling the Latest in Cardiac Health Research.The Journal fur Kardiologie, published by KRAUSE & PACHERNEGG GMBH, is a pivotal resource in the field of Cardiology and Cardiovascular Medicine. With an ISSN of 1024-0098 and an E-ISSN of 1680-936X, this journal has played a significant role in disseminating valuable research and clinical studies from 1998 until its coverage discontinuation in Scopus in 2017. Despite its Scopus rank being relatively low at #316/324 in its category, it continues to serve as a platform for emerging cardiology research. The journal’s scope encompasses various aspects of cardiovascular health, providing insights that are crucial for researchers, professionals, and students alike seeking to advance their knowledge and practice in cardiology. While the journal is not open access, its contributions to the field are essential for those looking to stay informed about the latest developments in cardiovascular medicine.